WGU Pathophysiology Final Exam Related

Review WGU Pathophysiology Final Exam related questions and content

A patient with osteoporosis is prescribed raloxifene (Evista). What is the primary therapeutic action of this medication?

  • A. It decreases bone resorption and increases bone density.
  • B. It stimulates the formation of new bone.
  • C. It increases calcium absorption in the intestines.
  • D. It increases the excretion of calcium through the kidneys.
Correct Answer: A

Rationale: The correct answer is A. Raloxifene works by decreasing bone resorption and increasing bone density. This helps in preventing further bone loss and reducing the risk of fractures in patients with osteoporosis. Choice B is incorrect because raloxifene does not stimulate the formation of new bone, but rather helps to maintain existing bone mass. Choice C is incorrect as raloxifene does not directly increase calcium absorption in the intestines. Choice D is also incorrect as raloxifene does not increase the excretion of calcium through the kidneys.